TERMINATED

Genome, Proteome and Tissue Microarray in Childhood Acute Leukemia

NCT01108497•Stanford University

Summary

We will study gene and protein expression in leukemia cells of children diagnosed with acute leukemia. We hope to identify genes or proteins which can help us grade leukemia at diagnosis in order to: (a) develop better means of diagnosis and (b) more accurately choose the best therapy for each patient.

Eligibility

Age

0 - 18 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•2\. Signed informed consent

Locations (1)

Stanford University School of Medicine

Stanford, California, United States

Key Dates

Start Date

July 1, 2001

Primary Completion Date

September 1, 2015

Completion Date

September 1, 2015

Last Updated

June 24, 2016

Enrollment

235

ACTUAL participants

Conditions

Leukemia

Interventions

Bone Marrow Aspiration

PROCEDURE

Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants

NCT00106925

Graft-versus-leukemiaGraft vs Host Disease+1 more

View study

RECRUITINGPHASE1

Phase I Study of HC-7366 for Acute Myeloid Leukemia

NCT06285890

Acute Myeloid Leukemia

View study

RECRUITING

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 24, 2016Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

PHASE2